Proxy Statement Reveals No Executive Cash Bonuses for 2025 Amid Continued Net Losses
XXII is trading near its 52-week low of $1.57 (6.1% above the low).
Summary
22nd Century Group's definitive proxy statement discloses that executive officers received no cash bonuses for 2025 due to unmet performance targets, reinforcing concerns about the micro-cap company's financial health and operational struggles.
Key Events · Corporate Governance and Compliance · XXII
-
No Executive Cash Bonuses for 2025
Executive officers, including the CEO, did not achieve performance-based cash bonuses for fiscal year 2025 due to the company not meeting its revenue or profit targets.
-
Ongoing Financial Underperformance
The company reported increasing net losses from 2022 to 2025, as detailed in the Pay vs Performance table, reinforcing prior "going concern" disclosures.
-
High Executive Compensation Amid Losses
Despite the lack of cash bonuses and increasing net losses, the total compensation for the PEO in 2025 was $939,735, which is a substantial amount given the company's financial performance.
-
Routine Shareholder Proposals
The filing outlines standard proposals for the upcoming Annual Meeting on June 11, 2026, including the re-election of one director, an advisory vote on executive compensation, and auditor ratification.
Analysis · XXII · Manufacturing
This definitive proxy statement highlights significant operational challenges at 22nd Century Group, Inc., a micro-cap company facing substantial doubt about its ability to continue as a going concern. The filing reveals that no performance-based cash bonuses were achieved by executive officers for fiscal year 2025 due to the company not meeting its revenue or profit targets. This, coupled with increasing net losses from 2022 to 2025 and substantial executive compensation, underscores the ongoing financial pressures and performance struggles. Investors should note the company's continued efforts to scale its VLN® products but remain cautious given the persistent financial underperformance.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 29.9% of the 1656 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, XXII was trading at $1.67 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $1.2M. The 52-week trading range was $1.57 to $489.90. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.